Vaccination

FIP’s work on vaccination is based on the conviction that improving vaccination coverage and promoting a life-course approach to vaccination are global imperatives to which pharmacists can greatly contribute. Of the 21 FIP Development Goals launched in September 2020, vaccination is linked to 17 goals, which clearly indicates the high priority vaccination holds not only for pharmacy and FIP, but also for global health. In particular, Development Goal 16, focusing on communicable diseases, is overtly linked to the prevention of this group of diseases, in which vaccination plays a prominent role.

With adequate training, pharmacists are competent to perform a series of roles that can significantly contribute to improving vaccination coverage, from providing evidence-based advice on vaccines and addressing vaccine hesitancy and complacency, to administering vaccines and managing vaccination records. Although pharmacists have administered vaccines in several countries for years, this role is still new or even unknown to the profession in many parts of the world. With the resources in this microsite, FIP aims to support its member organisations and pharmacists

This microsite is a resource hub aggregating FIP’s publications, partnerships and events in the area of vaccination, to support FIP’s members and individual pharmacists around the world in promoting vaccination awareness and confidence and expanding vaccination coverage globally across all ages and population groups.

Publications

FIP’s publications in this area range from the FIP-WHO Good Pharmacy Practice guidelines (2011) to advocacy tools, global data, guidelines and practice support tools. They include a members-only advocacy toolkit to support member organisations’ advocacy for the implementation of pharmacy-based vaccination, a collection of evidence and guidelines for the development of vaccination services, survey reports on the evolving roles of pharmacy in vaccination, and a regulatory self-evaluation assessment tool for advancing pharmacy services in this area.

Optimising vaccination through coadministration of influenza and COVID-19 vaccines: Guidance for pharmacists

This new guidance for pharmacists explores how vaccination strategies for two important respiratory conditions — COVID-19 and influenza — can and should be considered together and combined in an effective and impactful way to improve uptake rates for each vaccine.

Read Publication

Regional challenges and enablers to leveraging pharmacists as vaccinators

FIP organised in February and March 2022 a series of six regional roundtables with some of its member organisations and other key stakeholders from each region. These events were codeveloped and led by the FIP Forum of Professional Regulators and identified the drivers and barriers to the implementation of pharmacist-led vaccination in each region. In particular, they discussed the existing
challenges to interprofessional understanding, cooperation and task sharing in the area of vaccination.
Discussion topics included the regulatory authority granted to different healthcare professionals to prescribe and administer vaccines and the plans for the management of anti-COVID-19 vaccination in a post-pandemic scenario.

Read Publication

The FIP vaccination reference guide. Knowledge and skills to support professional development and inform pharmacy education in vaccination

Pharmacists in many parts of the world play key roles in public health, including vaccination-related services. As
established advocates, educators and qualified providers of vaccines, pharmacists have a significant role in promoting
and supporting the uptake and monitoring of vaccination. Their roles include raising awareness of the benefits of
vaccination and improving immunisation coverage. To successfully deliver these important roles, pharmacists need to
obtain the required knowledge and skills in the area of vaccination.

“FIP vaccination reference guide: Knowledge and skills in pharmacy education and professional development” is
developed by FIP for educators and academic institutions, practitioners and professional organisations, and
policymakers. The reference guide outlines the knowledge and skills that should be acquired by students during their
undergraduate pharmacy education, and expands into the knowledge and skills that should be obtained by pharmacists
through professional development and training.

Read Publication

Advocating expansion of the pharmacist’s role in immunisation: A focus on diphtheria-tetanus-pertussis booster, COVID-19 and meningitis vaccinations

Pharmacists are contributing to expanded immunisation coverage globally, thereby reducing illness and deaths from vaccine-preventable diseases. The report provides intelligence from 36 countries around the world on pharmacists’ current role in vaccination services. The new data show that their role has expanded since the publication of a previous FIP report in 2020. This increase has been driven in part by the need for urgent and mass vaccination as a result of the COVID-19 pandemic, the report authors say.

Key findings include:

  • 78% of countries surveyed allow vaccines administration at community pharmacies, and a third of countries allow pharmacists to prescribe some vaccines.
  • The most common driver for vaccination in pharmacies was pharmacists’ desire to provide vaccination services.
  • Legislative, regulatory and advocacy efforts have contributed to expanding pharmacists’ role.

In addition, vaccination authority policy development, stakeholder engagement and acceptance of pharmacists’ role, logistics development, and education and training were highlighted as being necessary if pharmacists’ role in vaccination services is to be leveraged further

Read Publication

FIP commitment to leveraging pharmacists to build vaccine confidence and address vaccine hesitancy and complacency

Vaccine hesitancy – concerns related to vaccination or outright refusal to receive vaccines despite availability – is a major threat to global health and an important barrier to the success of vaccination strategies worldwidei. Barriers such as misinformation and distrust in vaccines can compromise not only the health of individuals but also public health as a whole.

The International Pharmaceutical Federation (FIP), which brings together 146 organisations of pharmacists, pharmaceutical scientists and pharmaceutical educators, and represents over four million pharmacists from around the world, believes it is essential that pharmacy and other civil society organisations join forces and outline synergistic and complementary advocacy actions for broader access to and convenience of vaccination services through a diversity of providers and pathways, and to address vaccine hesitancy from multiple perspectives.

Read Publication

Construir a confiança nas vacinas e comunicar o seu valor. Um manual para farmacêuticos. (2021)

Esta publicação identifica razões comuns de preocupação ou hesitação relacionadas com a segurança e eficácia das vacinas e propõe abordagens eficazes para as abordar de diversas formas através de campanhas lideradas pelas farmácias e através de interacções com pacientes individuais.

Read Publication

Building vaccine confidence and communicating vaccine value: A toolkit for pharmacists (2021)

This publication identifies common reasons for concern or hesitancy related to vaccine safety and efficacy and proposes effective approaches to address them in a variety of ways through pharmacy-led campaigns and through interactions with individual patients.

Read Publication

FIP Vaccination Handbook for Pharmacists (2021)

With this publication, FIP aims to support individual pharmacists with understanding how they can contribute to improving vaccination coverage through services ranging from patient education and advice, to logistical roles and the administration of vaccines. This handbook provides guidance on the practical implementation of these services and includes guidelines on the procedures, safety aspects, common risk points and frequently asked questions about vaccines and their administration.

Read Publication

Pharmacy based pandemic vaccination programme: regulatory self-assessment tool (2021)

This self-assessment tool will help to identify strengths and areas for improvement in order to inform pandemic planning efforts ahead of current and future waves of COVID-19. It is an aid to help national ministries of health and regulators in assessing pandemic preparedness and the state of legislation and regulations within their countries to facilitate mass vaccination and testing and enhanced patient care through pharmacists and community pharmacies.

Read Publication

Vacinação em farmácias contra doenças pandémicas: ferramenta de autoavaliação regulamentar (2021)

Esta ferramenta de auto-avaliação ajudará a identificar pontos fortes e áreas a melhorar, a fim de informar os esforços de planeamento pandémico antes das actuais e futuras vagas da COVID-19. É uma ajuda para ajudar os ministérios nacionais da saúde e os reguladores na avaliação da preparação para pandemias e do estado da legislação e dos regulamentos nos seus países, para facilitar a vacinação e os testes em massa e melhorar os cuidados aos doentes através dos farmacêuticos e das farmácias comunitárias.

Read Publication

Programme de vaccination contre la pandèmie en pharmacie: Un outil d’auto-évaluation des politiques (2021)

Cet outil d’auto-évaluation permettra d’identifier les points forts et les domaines à améliorer afin d’informer les efforts de planification pandémique avant les vagues actuelles et futures de COVID-19. Il s’agit d’un outil destiné à aider les ministères de la santé et les organismes de réglementation nationaux à évaluer la préparation à la pandémie et l’état de la législation et de la réglementation dans leur pays afin de faciliter la vaccination et le dépistage de masse et d’améliorer les soins aux patients par le biais des pharmaciens et des pharmacies communautaires.

Read Publication

Programa de vacunación antipandémica en farmácias: herramienta de autoevaluación normativa (2021)

Esta herramienta de autoevaluación ayudará a identificar los puntos fuertes y las áreas de mejora con el fin de informar sobre los esfuerzos de planificación de la pandemia antes de las olas actuales y futuras de COVID-19. Se trata de una ayuda para que los ministerios de sanidad y los organismos reguladores nacionales evalúen la preparación para la pandemia y el estado de la legislación y la normativa en sus países para facilitar la vacunación y las pruebas masivas y mejorar la atención a los pacientes a través de los farmacéuticos y las farmacias comunitarias.

Read Publication

Give it a shot: Expanding immunisation coverage through pharmacists (2020)

This resource offers practical guidance on implementing a vaccination service and sets out the roles and technical requirements for pharmacy-based vaccines-related services

Read Publication

Addendum to FIP COVID-19 Guidance (November 2020)

This document provides an update of the most relevant data regarding COVID-19 contained in the “FIP COVID-19 Guidance”

Read Publication

FIP call to action to expand the role of community pharmacies in vaccination, including against COVID-19 and future pandemic (2020)

This statement highlights the role of pharmacists in vaccination and in the promotion of vaccination coverage around the world.

Read Publication

An overview of pharmacy’s impact on immunisation coverage. A global survey (2020)

This report contains the findings of FIP’s latest survey (2020) of pharmacy’s impact on immunisation coverage. It evaluates different aspects of pharmacist-led immunisation, including advocacy and awareness activities, regulatory frameworks, vaccine administration, reimbursement models, training and certification, vaccination records, and limitations and barriers to the expansion of pharmacy practice to include vaccine administration. A total of 99 countries and territories participated, making this the most comprehensive report published on this subject to date.

Read Publication

FIP global vaccination advocacy toolkit Supporting and expanding immunisation coverage through pharmacists (2019)

Aims to provide FIP member organisations with cases and arguments for achieving or expanding the roles of pharmacists in increasing vaccination coverage and uptake. (Access exclusive to FIP member organisations.)

Members Only

71st World Health Assembly. Intervention on provisional agenda item 11.5 – Addressing the global shortage of, and access to, medicines and vaccines (2018)

This statement addresses the importance of access to medicines, medicine shortages and pharmacy in this context.

Read Publication

71st World Health Assembly. Intervention on provisional agenda item 12.7 – Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits (2018)

This statement highlights the alignment of FIP and WHO efforts in influenza vaccination and access to vaccines.

Read Publication

142nd Executive Board Meeting. Intervention on provisional agenda item 3.6 – Addressing the global shortage of, and access to medicines and vaccines (2018)

This statement highlights FIP’s work on the area of shortages and access to medicines.

Read Publication

140th WHO Executive Board Meeting. Intervention on provisional agenda item 8.3 ─ Addressing the global shortage of medicines and vaccines (2017)

This statement addresses the global shortage of medicines and vaccines and the role pharmacists can have in supporting this global issue.

Read Publication

140th WHO Executive Board Meeting. Intervention on provisional agenda item 9.1 – Global Vaccine Action Plan (2017)

This statement addresses the global vaccine action plan and FIP’s effort to increase vaccination uptake

Read Publication

70th World Health Assembly. Intervention on provisional agenda item 13.3 Addressing the global shortage of, and access to, medicines and vaccines (2017)

This statement addresses the importance of access to medicines and pharmacy in this context.

Read Publication

An overview of current pharmacy impact on immunisation. A global report (2016)

This publication reports the findings of the first FIP survey on the roles of pharmacists in vaccination, conducted in 2016.

Read Publication

Good Pharmacy Practice – Joint FIP/WHO Guidelines on GPP Standards for quality of pharmacy services (2011)

This document describes the key roles, functions and activities of pharmacists, including the administration of vaccines.

Read Publication

Events/Webinars

FIP organises digital events and webinars regularly to highlight different topics related to vaccination, share best practices and innovations and advocate for the role that pharmacy can play in improving access to vaccination services.

You may access the recordings of all past events through the links provided below. You may also want to check the upcoming digital events at www.events.fip.org.

Vaccines & special-risk groups: Cardiovascular diseases

July 21, 2022

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.

Learning objectives:
By the end of the session participants should be able to:
• Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
• Understand the main recommended vaccines for people living with cardiovascular diseases
• Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
– Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia

Panellists:
– Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina
– Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland
– John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA

Watch video

Vaccines & special-risk groups: Cardiovascular diseases (French translation)

July 21, 2022

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.

Learning objectives:
By the end of the session participants should be able to:
• Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
• Understand the main recommended vaccines for people living with cardiovascular diseases
• Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
– Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia

Panellists:
– Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina
– Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland
– John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA

Watch video

Vaccines & special-risk groups: Chronic Respiratory Conditions

June 29, 2022

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups, people living with chronic respiratory conditions have specific vaccination needs that will be discussed in this event.

By the end of the session participants should be able to:

-Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
-Understand the main recommended vaccines for people living with chronic respiratory diseases
-Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
-Peter Guthrey, Executive Committee Member of the Social and Administrative Pharmacy Section of FIP; Senior pharmacists – strategic policy The Pharmaceutical Society of Australia - Australia

Panelists:
-Ema Paulino,  President  National Association of Pharmacies, Portugal (ANF), Portugal
-Fiona Mosgrove, General Practitioner NHS Grampian, UK
-Carmen Baldonedo Mosteiro, Community Pharmacist. Member of the Respiratory task force of the Spanish Society of community Pharmacy (SEFAC), Spanish society of clinical, familiar and community Pharmacy (SEFAC), Spain

Watch video

Vaccines & special-risk groups: Chronic Respiratory Conditions (French translation)

June 29, 2022

La vaccination est l’une des mesures les plus efficaces pour prévenir la transmission des maladies et protéger les populations contre une variété de maladies qui ont un impact important sur les individus et les systèmes de santé. Globalement, en fournissant des services pharmaceutiques centrés sur la personne, les pharmaciens jouent un rôle clé pour garantir une vie saine et promouvoir le bien-être, ainsi que pour favoriser une utilisation plus efficace, rationnelle et généralisée des vaccins. Parmi les différents groupes de population à risque, les personnes vivant avec une affection respiratoire chronique ont des besoins spécifiques en matière de vaccination qui seront discutés lors de cet événement.

À la fin de la session, les participants devraient être en mesure de :

-Comprendre les risques auxquels ce groupe de population particulier est exposé en ce qui concerne les maladies évitables par la vaccination, ainsi que les avantages d’être vacciné.
-Comprendre les principaux vaccins recommandés pour les personnes vivant avec des maladies respiratoires chroniques.
-Discuter du rôle des pharmaciens dans l’éducation à la santé et la vaccination de ce groupe à risque particulier.

Modérateur :
-Peter Guthrey, membre du comité exécutif de la section de la pharmacie sociale et administrative de la FIP ; pharmaciens seniors – politique stratégique The Pharmaceutical Society of Australia – Australie

Panélistes :
-Ema Paulino, Président de l’Association Nationale des Pharmacies, Portugal (ANF), Portugal
Fiona Mosgrove, médecin généraliste NHS Grampian, Royaume-Uni.
-Carmen Baldonedo Mosteiro, pharmacien communautaire. Membre du groupe de travail sur les maladies respiratoires de la Société espagnole de pharmacie communautaire (SEFAC), Société espagnole de pharmacie clinique, familiale et communautaire (SEFAC), Espagne.

Watch video

The role of community pharmacies in COVID-19 booster vaccination: Opportunities and supply chain challenges in a post-pandemic scenario

April 26, 2022

Around the world, community pharmacies play an increasingly consolidated role in vaccination. During the pandemic, pharmacies’ accessibility made them a convenient place for vaccination against COVID-19 in several countries, increasing vaccination coverage and helping achieve herd immunity. As the world slowly begins to emerge from the pandemic, this event will discuss the role of community pharmacies in COVID-19 booster vaccination, and their challenges in vaccine supply logistics and cold storage solutions, particularly in a post-pandemic scenario. Key interventions by community pharmacists in vaccine supply logistics linked to COVID-19 from different parts of the world will be presented.

Learning objectives:

1. Understand the supply chain and distribution process of COVID-19 vaccines from manufacturer to hospitals, community pharmacies, and the public;

2. Explore the role of community pharmacies in vaccine supply logistics for COVID-19;

3. Discuss the challenges of COVID-19 booster vaccination supply logistics and cold storage solutions in community pharmacies, particularly in a post-pandemic scenario;

4. Explore supply models that involve community pharmacies contributing to population vaccination coverage in a post-pandemic scenario.

Moderator:
– Catherine Duggan, Chief Executive Officer FIP, the Netherlands

Panellists:
– Vibhu Paudyal, Associate Professor in Clinical Pharmacy University of Birmingham, UK
– Ronald T. Piervincenzi, Ph.D., Chief Executive Officer USP, USA
– Loganathan Fahrni, Senior lecturer and pharmacist Universiti Teknologi MARA, Malaysia

Watch video

Advocating for the role of pharmacists in diphtheria-tetanus-pertussis booster, COVID-19, and meningococcal meningitis vaccinations

April 25, 2022

The importance of vaccines creates opportunities for pharmacists and pharmacies to contribute to improving vaccination coverage. Since the publication of FIP’s 2020 report on vaccinations highlighting the role of pharmacists and pharmacies in this area, there has been a significant expansion in pharmacy-based vaccination and the scope of vaccines delivered by pharmacists and the pharmacy workforce. To kick off World Immunisation Week, this digital event will provide an overview of that expansion for tetanus, diphtheria, acellular pertussis booster, COVID-19, and meningitis vaccines. Moreover, it will allow participants to hear from countries in various stages of advocating for a broader role for pharmacists in vaccination.

Learning objectives:

  1. To identify the current role of the pharmacist in tetanus, diphtheria, acellular pertussis booster, COVID vaccination, and meningococcal meningitis vaccination.
  2. To explore needs, drivers, and barriers for expanding that role in countries that have regulated pharmacy-based vaccination services.
  3. To give examples from countries with pharmacy-based vaccination services  in advocating a broader role for pharmacists in vaccination

Moderators:

– Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education, University College London, United Kingdom

– Manjiri Gharat, FIP Vice-President, India

Panellists:

– Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, French Chamber of Pharmacists, France

– Zhi Shan Sujata, Pharmacist, Malaysian Pharmacists Society, Malaysia

–  Sham Moodley, Pharmacist,  Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc, South Africa

– Zeid Kilani, President, Jordan Pharmacists Association, Jordan

– Mas Rahman Roestan, Operational Director of PT Biofarma and Expert Council of Indonesian Pharmacists Association, Indonesian Pharmacists Association, Indonesia

– Irma Beatriz Caponi, Farmacéutica, COFA, Argentina

Facilitators & Speakers:

– Christopher John, FIP Lead for Data and Intelligence, UK 

– Zheng Kang Lum, PhD candidate, National University of Singapore, Singapore

– Allie Jo Shipman, Director, State Policy, National Alliance of State Pharmacy Associations, USA

– Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia

Watch video

Enabling multiprofessional vaccine prescribing and administration for improved uptake rates: Eastern Mediterranean Region

March 14, 2022

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

Enabling multiprofessional vaccine prescribing and administration for improved uptake rates: Southeast Asian Region

March 10, 2022

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

Enabling multiprofessional vaccine prescribing and administration for improved uptake rates: African Region

March 7, 2022

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

Permettre la prescription et l’administration multiprofessionnelles des vaccins pour améliorer les taux de prise en charge: Région africaine

March 7, 2022

Dans de nombreux pays, les taux de couverture vaccinale sont sous-optimaux et les services de vaccination sont essentiellement axés sur l’enfance.

Les objectifs visant à développer les parcours de vaccination consistent notamment à disposer de points de vaccination plus nombreux et facilement accessibles, d’un plus grand nombre de professionnels capables de fournir le service à un plus grand nombre de personnes et d’offrir des conseils sur les vaccins fondés sur des données probantes.

Watch video

Enabling multiprofessional vaccine prescribing and administration for improved uptake rates: European Region

March 3, 2022

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

Enabling multiprofessional vaccine prescribing and administration for improved uptake rates: Americas Region

March 1, 2022

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

Permitir la prescripción y administración multiprofesional de vacunas para mejorar las tasas de vacunación: Región de las Américas

March 1, 2022

En muchos países, las tasas de cobertura de vacunación no son óptimas, y los servicios de vacunación se centran principalmente en la infancia. Los objetivos para ampliar las vías de acceso a la vacunación incluyen disponer de más puntos de vacunación de fácil acceso, más profesionales que puedan prestar el servicio a un mayor número de personas y ofrecer asesoramiento basado en la evidencia sobre las vacunas. En este evento se debatirán los factores que impulsan y obstaculizan el entendimiento interprofesional, la cooperación y el reparto de tareas en el ámbito de la vacunación en la región, así como la autoridad normativa concedida a los distintos profesionales sanitarios para prescribir y/o administrar vacunas.

Watch video

Enabling multiprofessional vaccine prescribing and administration for improved uptake rates: Western Pacific Region

February 28, 2022

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

Leadership summit on pharmacy-based vaccination policy and advocacy

November 18, 2021

The Leadership Summit– the programme finale – is a high-level event in which we recap the primary outcomes of the 12-event digital series. Together, we will adopt the FIP Commitment to Action on sustainable and equitable access to vaccines through pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

Watch video

Presentación del documento técnico Servicios farmacéuticos en inmunización: aportes, experiencias e implementación en la región de las Américas.

November 17, 2021

El documento técnico, Servicios farmacéuticos en inmunización: Aportes, experiencias e implementación en la región de las Américas, elaborado por el Centro de Información de Medicamentos del Instituto de Investigaciones Farmacéuticas de la Facultad de Farmacia de la Universidad de Costa Rica para el Foro Farmacéutico de las Américas (FFA), ofrece una visión general de la participación del profesional en farmacia en temas de vacunas y en servicios farmacéuticos en inmunización en América Latina. En este webinar de presentación, se hará una reseña de sus contenidos y la relación con los objetivos de desarrollo de la Federación Internacional Farmacéutica (FIP). Este documento tiene la pretensión de constituirse en una herramienta para la implementación de servicios farmacéuticos en inmunización en la región que complementa las formuladas y emitidas por la FIP.

Watch video

Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the African region

November 4, 2021

In the final sixth of six regions we dissect, event 11 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the African region join us for a true regional perspective.

Watch video

Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the Western Pacific region

October 28, 2021

In the fifth of six regions we dissect, event 10 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Western Pacific region join us for a true regional perspective.

Watch video

Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the South East Asian region

October 26, 2021

In the fourth of six regions we dissect, event 9 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the South East Asian region join us for a true regional perspective.

Watch video

Joining forces across civil society organisations towards improved vaccination coverage

October 21, 2021

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. For FIP, it is essential to engage with civil society organisations representing different constituencies – from patient advocacy groups to older adult organisations and to vaccination advocates – to discuss and outline synergistic and complementary advocacy actions for broader access and convenience of vaccination services through a diversity of providers and pathways. This event gathered different civil society organisations to express their concerns, best practices and expectations, namely with regards to the role of pharmacists, for improving vaccination coverage, and to identify potential alignments in advocacy strategies.

Watch video

Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the European region

October 14, 2021

In the third of six regions we focuses on the regional needs and drivers for transforming vaccination in the European region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

Watch video

Confidence, complacency and convenience: Key elements of influenza vaccination strategies in times of COVID-19

October 12, 2021

This digital event discussed how important it is to promote confidence in influenza vaccines and avoid complacency towards vaccination due to lower influenza rates in the past year. Harnessing the convenience of access to pharmacies will be paramount to achieve these goals. Due to the widespread adoption of disease prevention measures to reduce transmission of COVID-19, the prevalence of the seasonal influenza lowered drastically around the world. However, as more people become vaccinated against COVID-19 and measures such as mask wearing, social distancing and home-based working or schooling are eased, the flu could return with high incidence rates and people could be more susceptible to the influenza virus due to lack of recent exposure. Developing flu vaccines this year has also been more challenging than usual due to less data available. This uncertainty around the return of influenza makes vaccination all the more critical, and it essential to communicate this to the population.

Watch video

Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the Eastern Mediterranean region

October 7, 2021

In the second of six regions we dissect, event 7 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Eastern Mediterranean region join us for a true regional perspective.

Watch video

Acceso sostenible y equitativo a las vacunas: Establecimiento de prioridades y fijación de políticas en la región de las Américas

October 1, 2021

En la primera de las seis regiones que analizaremos, este evento se centrará en las necesidades y los catalizadores a nivel regional para transformar las estrategias de vacunación en las Américas. Se trata de identificar las prioridades de los países de la región en materia de equidad y acceso a la vacunación. También discutiremos las barreras, los desafíos y las necesidades regionales en relación con el establecimiento de políticas de vacunación. Los miembros de la FIP, y otras organizaciones y socios relevantes de la región de las Américas participarán conjuntamente para obtener una verdadera perspectiva regional sobre este asunto.

Watch video

Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the Americas region

September 30, 2021

In the first of six regions we dissect, event 6 focuses on the regional needs and drivers for transforming vaccination in the Americas. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Americas region, join us for a true regional perspective.

Watch video

Working together across systems to transform vaccination policy: working with others in our professions, with other disciplines and agencies to establish sustainable policies

September 23, 2021

This event focused on intra and interprofessional alliances to ensure that we can work together to deliver the areas of policy addressed in this series. Panellists discussed working together with other agencies and policymakers to establish sustainable policies on vaccines access and equity, including how pharmacy can be a force of good in supporting vaccinations for all health workers.

Watch video

Understanding vaccine hesitancy and building vaccine confidence through effective conversations

September 8, 2021

The World Health Organization has listed vaccine hesitancy — concerns related to vaccination or outright refusal to receive vaccines despite availability — as one of the top 10 threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine-preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against COVID-19.

Watch video

Health illiteracy and vaccine misinformation as determinants for equity: developing policies to establish access to quality information in an equitable way

August 26, 2021

This event focused on the issues around health literacy and access to information. The societal influences on the ‘’infodemic’’ will be laid out, also the role of health care professionals, health workers and be vaccine hesitant people. We considered all the policy elements that need to be addressed to overcome this, identifying tools to overcome these issues from a range of angles and the role pharmacy can play.

Watch video

Vaccinations and the genders: Examining inequities in gender access and handling of vaccinations globally to inform pharmacy policy

August 10, 2021

Episode 3 examines inequities in gender access to vaccines to inform pharmacy policy. Various angles to vaccinations and the gender will be discussed including general gender access, terms of empowering women as caregivers to support vaccinations, the impact of COVID-19 on gender inequity, and the issues around gender inequity in the workforce (which is especially important to discuss in 2020 Year of the Health Worker).

Watch Video

Developing Effective Pharmacy-led Vaccination Campaigns

July 26, 2021

The World Health Organization lists vaccine hesitancy—concerns related to vaccination or outright refusal to receive vaccines despite availability—as one of the top ten threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against novel Sars-Cov-2 virus.

Often times, “one-size-fits-all” vaccine promotion efforts can backfire when presented to individuals who are already sceptical of vaccines. This event will outline evidenced-based strategies for developing pharmacy-led immunization campaigns which communicate the value of vaccines to specific patient groups in order to build vaccine confidence and improve uptake.

Watch Video

Equity, access & sustainability through life’s ages and stages: Enabling a life course-approach to vaccination

July 8, 2021

Episode 2 takes a life-course approach to discussing vaccination. The panelists will focus on age and explore vaccines equity and access through life’s ages and stages – from childhood (including pregnancy) to later adulthood – from a pharmacy perspective. They will focus on setting out the policy issues and immediate next steps, determining what pharmacy needs to do to singularly affect the most change in this area.

Watch Video

Joining forces across health professionals towards improved vaccination coverage

June 29, 2021

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. As such, FIP considers that it is essential to promote dialogue and understanding around these perceptions among healthcare professionals’ organisations at the international level, so that these can be cascaded to the regional, country and local levels.

Watch Video

Introducing the FIP ‘Transforming Vaccination Globally, Regional and Nationally’ 2021: Accelerating equity, access and sustainability through policy development and implementation

June 17, 2021

Episode 1, the digital programme’s Opening Event, will set the stage for the entire programme. Together we will revisit the key outcomes of the Transforming Vaccination 2020 programme, specifically focusing on the outcomes relating to shaping policy around equity, access and sustainability and how they are shaping the FIP vaccination agenda for 2021. We will also describe this year’s programme, outline its key aims and objectives as well as outcomes. This special programme opener is for anyone invested in transforming and shaping vaccination in pharmacy!

Watch Video

Pharmacists’ involvement in COVID-19 vaccination: Addressing regulatory needs

February 4, 2021

FIP’s Regulators’ Forum presented a new regulatory vaccination preparedness self-assessment tool and risk assessment. Foundational regulatory needs were presenteded to ensure oversight, quality assurance and public protection as the scope of pharmacist’s patient care is expanded to include prescribing, vaccination and testing in order to address population health needs during a pandemic. A brief overview of the data collected by FIP on the role of pharmacists in vaccinations and other FIP documents was also presented.

Watch Video

Global Immunization Initiatives: Implementing Lifelong Learning to Address Mass Vaccination

January 21, 2021

This session will examine the application of the concepts of the Health Belief Model (HBM) which is one of the first and still most commonly used frameworks or theories of health behavior. There has been successful application of the HBM in health and wellness programs, including immunization and chronic diseases management. As such, the application of HBM will be illustrated in a flu awareness campaign that targeted Lebanese University students. Examples of improving immunization rates and addressing patient perceptions in an ambulatory care setting in the U.S. will also be discussed.

Watch Video

Vaccine administration routes and procedures: frequent concerns and common errors

January 13, 2021

Although pharmacists have administered vaccines in several countries for years, this role is still new or even unknown to the profession in many parts of the world. As a role that involves direct contact with the patient and the administration of a product by injection, it may still generate some concerns among pharmacists with regards to the administration procedure, common errors and the management of anaphylactic reactions. This webinar will describe such procedures and address common questions and concerns.

Watch Video

FIP Global Virtual Summit: Committing to action to transform vaccination in pharmacy

December 17, 2020

This global virtual Summit – the programme finale – is a high-level event in which we will recap the primary outcomes of the 24-event digital series. Together, we will adopt the FIP Commitment to Action on Vaccination in Pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

Watch Video

From regional to global: Common priorities for action to transform vaccination

December 15, 2020

This roundtable event follows 6 regional events – episodes 3.1 to 3.6 of the programme – which dissected priorties, needs and barriers across the world’s six regions. We now bring back the key outcomes from the six regional discussions int one roundtable to identify common priorities for action to transform vaccination. Each regional perspective will be represented by the panelists, alongside other leaders and stakeholders.

Watch Video

Necesidades e impulsores regionales de la transformación de la vacunación: Américas

December 10, 2020

Event 3.6 focuses on the regional needs and drivers for transforming vaccination in the Americas region. This involves discussing the progress made in countries in the Americas with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation.

Watch Video

Regional needs and drivers for transforming vaccination: Africa

December 9, 2020

In the fifth of six regions we dissect, event 3.5 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves discussing the progress made in Africa with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from Africa join us for a true regional perspective.

Watch Video

Regional needs and drivers for transforming vaccination: Western Pacific

December 8, 2020

In the fourth of six regions we dissect, event 3.4 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific. This involves discussing the progress made in Western Pacific countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the Western Pacific join us for a true regional perspective.

Watch Video

Regional needs and drivers for transforming vaccination: Eastern Mediterranean

December 3, 2020

In the third of six regions we dissect, event 3.3 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region (EMR). This involves discussing the progress made in EMR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the EMR join us for a true regional perspective.

Watch Video

Regional needs and drivers for transforming vaccination: South East Asia

December 2, 2020

In the second of six regions we dissect, event 3.2 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region (SEAR). This involves discussing the progress made in SEAR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the SEAR join us for a true regional perspective.

Watch Video

Regional needs and drivers for transforming vaccination: Europe

December 1, 2020

In the first of six regions we dissect, event 3.1 focuses on the regional needs and drivers for transforming vaccination in Europe. This involves discussing the progress made in European countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

Watch Video

Communicating vaccine safety, building vaccine confidence

November 27, 2020

This event will discuss how the quality, efficacy and safety of vaccines are built into their development and manufacturing processes, including the clinical research they undergo and the strict regulatory assessment that precedes their marketing authorization. In addition, speakers will discuss how to make such processes understood and well-known by the public in a transparent and clear manner, in order to build confidence in vaccines and address the grave problem of vaccine hesitancy and anti-vaccines movements, i.e., the refusal to get vaccinated despite the availability of vaccines.

Watch Video

Setting transformative goals for vaccination globally

November 25, 2020

In this episode – “Setting Transformation Goals for Vaccination Globally” – is a roundtable discussion that focuses on the role of the FIP Development Goals in the transformation of pharmacist vaccination globally and regionally. The discussion will focus on the development of transformative goals and how these goals will be used to deliver pharmacist vaccinators in all jurisdictions, resulting in increased vaccination rates worldwide

Watch Video

Pharmacist vaccinators and patient safety: FIP DG 19 Patient Safety

November 11, 2020

In this episode – “Pharmacist Vaccinators as a way to improve access to medicines” – is an interview format that focuses on the FIP Development Goal 18: Access to Medicines and Services from the perspective of vaccination by a pharmacist. The role of pharmacists in ensuring that vaccinations are widely and easily accessible by all people in all areas of the world, and the expertise of pharmacists in delivering the logistics and services needed to increase vaccination rates.

Watch Video

Pharmacist vaccinators and antimicrobial stewardship: FIP DG 17 Antimicrobial Stewardship

November 11, 2020

In this episode – “Pharmacist Vaccinators and Antimicrobial Stewardship” – is an interview format that focuses on the FIP Development Goal 17: Antimicrobial Stewardship from the perspective of vaccination by a pharmacist. The role of vaccination in antimicrobial stewardship, preserving antimicrobial effectiveness, preventing antimicrobial resistance, and the promise of addressing these issues that pharmacists vaccinators will deliver.

Watch Video

Pharmacist vaccinators and communicable disease management: FIP DG 16 Communicable Diseases

November 10, 2020

In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

Watch Video

Removing policy barriers to pharmacist vaccinations: FIP DG 13 Policy Development

November 5, 2020

In this episode, “Removing Policy Barriers to Pharmacist Vaccination” – is an interview format that focuses on the FIP Development Goal 13: Policy Development from the perspective of vaccination by a pharmacist. We discuss the process of policy development, identification of barriers, and engagement with stakeholders to ensure that pharmacist vaccination is accessible to all people in all settings where pharmacists work.

Watch Video

Empowering pharmacists to deliver vaccination at the health-system level: FIP DG 7 Advancing Integrated Services

November 3, 2020

In this episode, “Empowering Pharmacists to Deliver Vaccination in all Settings” – is an interview format that focuses on the FIP Development Goal 7: Advanced Integrated Services from the perspective of vaccination by pharmacist. We discuss change management principles in the context of integrating advanced practice services into every day practice, ensuring that vaccination by pharmacists in all settings and jurisdictions is consistent with best evidence and practice guidelines. Where a pharmacist is present in all settings, vaccinations can be provided. Ensuring collaborative work and shared documentation with all healthcare professionals to ensure it is an integrated service.

Watch Video

Vaccination from specialist practice to every day practice: FIP DG 4 Advanced & Specialist Development

October 28, 2020

In this episode – “Vaccination: From Specialist Practice to Everyday Practice” – is an interview format that focuses on the FIP Development Goal 4: Advanced & Specialist Development from the perspective of vaccination by a pharmacist. We discuss the process required to take vaccination by pharmacists from a specialized field that few pharmacists deliver in some jurisdictions, to a standard part of pharmacists’ care in all settings and locations.

Watch Video

L’hiver arrive : La vaccination contre la grippe en période de COVID-19. Bonnes pratiques des pays francophones

October 22, 2020

La grippe saisonnière représente une charge de morbidité importante pour le système de santé et un risque pour plusieurs groupes de population, notamment les personnes âgées, les personnes souffrant d’affections sous-jacentes, les femmes enceintes et d’autres.
La menace d’une deuxième épidémie de COVID-19 est très réelle, et le risque que les deux virus entraînent une morbidité et une mortalité combinées ne peut être négligé.

Watch Video

Reviewing the FIP Transforming Vaccination Programme: Enabling and supporting our profession

October 21, 2020

Scope: Transforming Vaccination with the FIP Development Goals: Brining practice, science and workforce together

What were the key insights and summaries from each of the events so far?

What was the one key message you gathered from that presentation, what was the main need identified from the presentation?

What is one key change you think that could be implemented to address this change?

Watch Video

FIP Transforming Vaccination Globally and Regionally. Transforming our workforce: Evolving the pharmacist’s qualification

October 15, 2020

Watch Video

Avances en el desarrollo de vacunas contra COVID-19 e importancia de la vacunación en tiempos de pandemia

October 7, 2020

Tras la irrupción de la infección respiratoria por el nuevo coronavirus SARS-CoV-2, el desarrollo de vacunas capaces de proporcionar protección individual y poblacional frente a este virus se presenta como uno de los pilares fundamentales para controlar su expansión. Por otro lado, entre los numerosos efectos de la pandemia actual, conviene destacar los relacionados con la interrupción de los servicios básicos de salud, entre ellos, los programas de vacunación que están sufriendo importantes caídas y demoras en la mayoría de los países. En esta conferencia se abordarán las diferentes vacunas que se están en progreso para COVID-19, las tecnologías utilizadas y los adelantos en su desarrollo, así como la importancia de reestablecer y mantener los sistemas de inmunización.

Watch Video

From smallpox to COVID-19: Vaccine development & innovation

October 6, 2020

Watch Video

Addressing barriers to uptake: Adherence, misinformation & anti-Science

October 5, 2020

Watch Video

Enabling practice: Empowering pharmacists & removing barriers

October 2, 2020

Watch Video

Transforming practice: A focus on strategy & policy for global change

October 1, 2020

Watch video

Introducing the FIP ‘Transforming Vaccination Globally & Regionally’ series Programme… needs, action and outcomes

September 25, 2020

Watch Video

The value of vaccines for society and special populations

September 18, 2020

Watch Video

Influenza vaccination – Strategic elements of development, supply and delivery for optimal prevention

September 16, 2020

Watch Video

Can the world afford low vaccination coverage rates? Broadening vaccination gateways through pharmacies

September 15, 2020

Watch Video

Give it a shot: Advocating for pharmacy-based vaccination and achieving legislative changes

September 3, 2020

Watch Video

An overview of current pharmacy impact on immunisation – Presentation of key findings from FIP’s global report 2020

August 6, 2020

Watch Video

Increasing vaccination coverage through pharmacists | Episode 2: Who’s immune to fake news? Addressing patient motivation and vaccine hesitancy

July 28, 2020

Watch Video

Winter is coming: Influenza vaccination in times of COVID19–Best practices from Southern Hemisphere

July 2, 2020

Watch Video

Mass vaccination campaigns

April 23, 2020

Watch Video

Partnerships

Partnerships are crucial to advocate for a broader role for pharmacy in vaccination. Over the years, FIP has collaborated and joined efforts with several organisations with aligned agendas in the area of vaccination.

The different organisations that have worked with FIP in this area are highlighted in this section, including the details of their partnership and areas of collaboration.

Influenza Diabetes Community

Founded in 1998, The European Scientific Working group on Influenza and other Respiratory Viruses (ESWI) is a network organisation that aims to reduce the burden of influenza and other acute respiratory viruses in Europe. The Influenza Diabetes Community is a focus area for ESWI and serves as a virtual reference center, containing materials supplied by the IDC members on the importance of influenza vaccination for people with diabetes.

People with diabetes still face a higher risk for influenza and its complications. National and international guidelines therefore advise that diabetes patients be annually vaccinated against influenza. More information can be found in the Influenza Diabetes Community website.

FIP is a member of the IDC since 2020. This gives us the opportunity to voice and advocate for the role that pharmacists can play both in immunisation and in the care of people living with diabetes. It also gives us access to an interdisciplinary forum of experts in this area, which supports FIP in advancing our work on these topics.

IFAA – Immunisation for all ages

Initiative Overview

The goal of the Immunisation for All Ages initiative is to accelerate and advance policies that advocate for life-course vaccination by communicating the broader societal value of vaccination for all stages of life at a global and local level, such that policymakers, NGOs, governments, healthcare providers (HCPs) and citizens will support policies that prioritize vaccinations. The mission of IFAA is to expand and improve public awareness and policies that advocate for life course vaccination by learning from and building upon good practices and championing initiatives that will protect lives at all stages around the world. The IFAA is supported by Pfizer.

Steering Committee

The Immunisation for All Ages Steering Committee is responsible for guiding the direction and activities for the initiative with two overarching objectives:

  • Identify where the Immunisation for All Ages network is uniquely positioned to address the current challenges, expand awareness, acceptance and access to life-course vaccination advocacy, as well as conduct strategic action planning using insights of the evolving global landscape for life course vaccination;
  • Provide guidance and advice on leveraging annual summits to advance the collective strategic vision and lead initiatives that will be supported by a working group of other Immunisation for All Ages initiative participants or members.

Current Steering Committee members include:

  • Confederation of Meningitis Organizations (CoMO) – President, Chris Head
  • The International Federation of Ageing (IFA) – Secretary General, Jane Barratt
  • The International Longevity Centre (ILC) – Director, David Sinclair
  • Shot@Life – Executive Director, Martha Rebour
  • The International Pharmaceutical Federation (FIP) – Lead for Practice Development and Transformation, Gonçalo Sousa Pinto
  • World Federation of Public Health Associations (WFPHA) – Immediate Past President, Michael Moore
  • Justin Ortiz, Associate Professor, Center for Vaccine Development and Global Health, University of Maryland

Promoting immunisation throughout life –IFAA Manifesto

The Immunisation for All Ages Initiative is working to improve the uptake rates of immunisation throughout life globally. This manifesto aims to support combatting inequity and improving access to immunisation to promote healthy people throughout life, to preserve function and to prevent death and disability.

IFAA position paper- Protecting and Progressing Routine Immunisation

Urgent work is needed to ensure any disruption to immunisation programmes from the pandemic is mitigated to protect the decades of progress made against vaccine-preventable diseases. Routine immunisation and efficient catch-up strategies for people at all stages of life are key elements needed for the health, well-being and prosperity of communities and countries. Given the disruptions inflicted by the pandemic on immunisation programmes, innovative solutions must be found to maximise routine immunisation uptake across all countries.

IFAA position paper – Expanding capacity for immunisation beyond infancy

In addition to the well-known benefits of childhood immunisation, vaccines help to protect health throughout life and are a key component of healthy ageing. In particular, immunisation programmes for adult respiratory diseases such as influenza can substantially mitigate the annual burden of disease (increased mortality, morbidity, and healthcare costs), particularly among populations at greater risk of infection. Provision of vaccination by pharmacists is cost-effective and known to increase vaccination uptake. Increased utilisation of pharmacists will help alleviate pressure on current vaccine infrastructure, reduce potential disruption to routine immunisation beyond infancy, and strengthen health system capacity and vaccine coverage.

IFAA position paper – Restructuring health systems towards prevention

Immunisation plays a central role in the health promotion and prevention agenda and is a key component of healthy ageing and universal health coverage. Current health systems need to reorient from treating disease to preventing it at all stages of life. For example, investing in influenza vaccination saves time, money and lives, and leads to healthier, more sustainable healthcare systems and communities.

Webinar “Immunization for All Ages – Driving Policy to Action”

Learn through this webinar how global strategies such as the WHO Decade of Healthy Ageing (2020-2030) and WHO Immunisation Agenda 2030: A Global Strategy can be meaningfully implemented at a national level and what role civil society can play in driving change through the three interconnected pillars of prevention, access and equity.

Webinar “Defeat meningitis”

Meningitis is deadly and debilitating. It strikes quickly, has serious health, economic and social consequences, and affects people of all ages, but particularly children under 5 years of age. If all people are to gain access to life-saving vaccines, major challenges must be overcome – vaccines must be delivered to marginalized populations, to displaced and migrating individuals, and to those affected by conflict, political instability and natural disasters. New approaches are needed to reach populations other than infants and to deliver integrated immunization and other health services in people-centred ways, as a part of primary health care to reach universal health coverage. This webinar explores the steps to implementing the roadmap for defeating meningitis, toward improving awareness and achieving higher vaccine coverage at a country level.

International Federation of Pharmaceutical Manufacturers and Associations – Influenza Vaccine Supply – IFPMA IVS

The Covid-19 pandemic has taught us a lot. Amongst other things, we’ve learnt about the importance of protecting the most vulnerable people in our societies, particularly older adults and patients with underlying medical conditions.
We need to improve influenza vaccination rates and, in doing so, reduce the burden of influenza disease nationally, regionally and globally. That’s why the IFPMA, IFA and FIP have joined forces to develop a common basis for a network communication strategy around influenza vaccination.
We’ve been working on our #TogetherAgainstFlu online campaign, together with the digital agency ZN. The objective is to keep raising awareness of the importance of flu vaccination and herd immunity for healthcare workers, older adults and patients living with chronic conditions, such as respiratory and heart diseases.
We are taking a network approach to reach these audiences. Evidence-based messages targeted at different stakeholders, opinion leaders and decision-makers will support their advocacy for implementation of existing recommendations for the prevention and control of seasonal influenza.
And we are looking to expand our influenza network. We are looking for other groups/organizations to partner with us in sharing the campaign messages across their audiences.
Join the influenza network. Help us spread us the messages around the importance of flu vaccination.

Vaccines Today

Vaccines Today has been online since 2011. The site is supported by Vaccines Europe, independently accredited by Health on the Net and is an active member of the WHO Vaccine Safety Net network. Its content is written by professional health journalists and actively reviewed by an Editorial Board of doctors, scientists and patient representatives. FIP is proudly joining this group of more than 20 organisations including the Immunization Action Coalition, History of Vaccines, the World Medical Association and Vaccine Ambassadors in the promotion of vaccination uptake and coverage around the world.

Transforming Vaccination Programme

In partnership with Pfizer, in 2020 FIP launched the first digital programme of its kind “Transforming Vaccinations Globally and Regionally” that addresses the essential role pharmacists play in saving the lives of millions through the provision of vaccines. The programme was a three-part series, each consisting of 8 online events.

In 2021, FIP is renewing its partnership with Pfizer and is launching its second programme that focuses more on the equity and sustainability of vaccinations. Building on the outcomes of the 2020 programme, the FIP 2021 digital programme focuses on supporting FIP members in accelerating programmes of equity, access and sustainability of vaccinations through policy development and implementation. The 12 events explore equity in vaccinations across the different angles of age, gender, literacy & education, and interprofessional unity & collaboration. Regional roundtables will discuss and identify priorities for sustainable access to vaccinations through pharmacies around the world. The programme will result in a FIP commitment to accelerate equity, access and sustainability through policy development and implementation, as well as a special policy collection capturing the outcomes of this transformation programme.

The full details of this programme can be found at its dedicated website https://transformingvaccination.fip.org/